Cooper Creek Partners Management LLC reduced its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 23.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,814,679 shares of the company's stock after selling 873,565 shares during the period. Bath & Body Works comprises approximately 3.4% of Cooper Creek Partners Management LLC's holdings, making the stock its 7th largest holding. Cooper Creek Partners Management LLC owned about 1.30% of Bath & Body Works worth $109,125,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new stake in Bath & Body Works in the fourth quarter worth $26,000. SRS Capital Advisors Inc. lifted its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after purchasing an additional 329 shares during the last quarter. UMB Bank n.a. lifted its position in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC boosted its stake in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works in the 3rd quarter worth about $39,000. 95.14% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on BBWI shares. Barclays reduced their price objective on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research report on Monday, March 3rd. Cowen reissued a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. JPMorgan Chase & Co. lowered their price objective on shares of Bath & Body Works from $47.00 to $41.00 and set an "overweight" rating on the stock in a research note on Monday. Robert W. Baird upped their target price on Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research report on Friday, February 28th. Finally, Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and an average price target of $43.13.
View Our Latest Stock Report on Bath & Body Works
Bath & Body Works Trading Up 3.4 %
NYSE:BBWI traded up $0.92 on Friday, hitting $28.42. 4,852,461 shares of the company's stock traded hands, compared to its average volume of 4,727,089. The company has a market cap of $6.09 billion, a PE ratio of 6.93, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 1 year low of $24.96 and a 1 year high of $52.99. The firm has a 50-day moving average price of $32.29 and a 200-day moving average price of $33.86.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating analysts' consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.81%. Bath & Body Works's payout ratio is 21.98%.
Bath & Body Works announced that its board has authorized a share buyback program on Thursday, February 27th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its shares are undervalued.
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.